These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


83 related items for PubMed ID: 843073

  • 21. Determination of milk withholding time in cattle following use of intramuscular lincomycin.
    Pearson A.
    Vet Rec; 1989 Dec 09; 125(24):601. PubMed ID: 2609484
    [No Abstract] [Full Text] [Related]

  • 22. Therapeutic effects of parenteral administration of lincomycin on experimentally transmitted swine dysentery.
    Hamdy AH, Kratzer DD.
    Am J Vet Res; 1981 Feb 09; 42(2):178-82. PubMed ID: 7258765
    [Abstract] [Full Text] [Related]

  • 23. Lincomycin and penicillin G in the treatment of mild and moderately severe pneumococcal pneumonia. A comparative study.
    Anderson R, Bauman M, Austrian R.
    Am Rev Respir Dis; 1968 May 09; 97(5):14-8. PubMed ID: 4384776
    [No Abstract] [Full Text] [Related]

  • 24. Lung tissue concentrations of ciprofloxacin following intravenous administration in patients.
    Forst H, Ruckdeschel G, Unertl K, Dieterich HJ, Ehret W, Sunder-Plassmann L.
    Arzneimittelforschung; 1989 May 09; 39(5):618-9. PubMed ID: 2757681
    [Abstract] [Full Text] [Related]

  • 25. [Experimental pharmacodynamic study of rifampicin administered by various methods].
    Shapovalov VP, Mil'chenko KP, Kovalenko NN.
    Antibiotiki; 1982 Jun 09; 27(6):434-7. PubMed ID: 7114830
    [Abstract] [Full Text] [Related]

  • 26. [Levels of sulfametrole-trimethoprim in blood and lung-tissue during treatment of respiratory tract infection (author's transl)].
    Wieser O, Haiderer O, Takacs F.
    Wien Med Wochenschr; 1981 Jun 09; 131(13-14):363-6. PubMed ID: 7281703
    [Abstract] [Full Text] [Related]

  • 27. [Absorption, distribution and excretion from animal organism of abtibiotic lincomycin].
    Kunrat IA.
    Antibiotiki; 1968 Jul 09; 13(7):613-7. PubMed ID: 5696456
    [No Abstract] [Full Text] [Related]

  • 28. Adverse reactions to parenteral lincomycin.
    Berry DD, Brouhard BH, Box QT.
    Pediatrics; 1981 Mar 09; 67(3):389-91. PubMed ID: 7017577
    [Abstract] [Full Text] [Related]

  • 29. [Time-course of the concentration of cefotiam in human extra-vascular pulmonary tissue].
    Ohkuda K, Ichinose T, Inaba H, Sakuma T, Tanita T.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Feb 09; 29(2):225-30. PubMed ID: 2033896
    [Abstract] [Full Text] [Related]

  • 30. Parenteral clindamycin in the treatment of infections.
    Donoho CR.
    Del Med J; 1971 Nov 09; 43(11):391-3. PubMed ID: 5122253
    [No Abstract] [Full Text] [Related]

  • 31. Data on sisomicin effect: human pharmacokinetic and bacteriological studies.
    Faragó E, Kiss IJ, Mihóczy L.
    Int J Clin Pharmacol Ther Toxicol; 1980 Mar 09; 18(3):128-32. PubMed ID: 7380585
    [Abstract] [Full Text] [Related]

  • 32. Lincomycin serum and saliva concentrations after intramuscular injection of high doses.
    Smith RB, Lummis WL, Monovich RE, DeSante KA.
    J Clin Pharmacol; 1981 Oct 09; 21(10):411-7. PubMed ID: 7309904
    [Abstract] [Full Text] [Related]

  • 33. Use of gentamicin physiologically-based model for individual dosing.
    Manuilov KK, Navashin SM, Kuleshov SE.
    Int J Clin Pharmacol Res; 1993 Oct 09; 13(2):59-63. PubMed ID: 8354589
    [Abstract] [Full Text] [Related]

  • 34. Tylosin concentrations in rat serum and lung tissue after administration in drinking water.
    Carter KK, Hietala S, Brooks DL, Baggot JD.
    Lab Anim Sci; 1987 Aug 09; 37(4):468-70. PubMed ID: 3669599
    [Abstract] [Full Text] [Related]

  • 35. [Pulmonary and bronchial kinetics of cefuroxime after a single 500 mg intramuscular injection].
    Le Gros V, Farinotti R, Brion N, Regnard JF, Azorin J, Parrot AM, Chiche D.
    Pathol Biol (Paris); 1992 May 09; 40(5):545-50. PubMed ID: 1495842
    [Abstract] [Full Text] [Related]

  • 36. Amoxycillin levels in human serum, bile, gallbladder, lung, and liver tissue.
    Kiss IJ, Faragó E, Schnitzler J, Várhelyi I.
    Int J Clin Pharmacol Ther Toxicol; 1981 Feb 09; 19(2):69-74. PubMed ID: 7216553
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of lung tissue and hilar lymph node concentrations of azithromycin.
    Cazzola M, Siniscalchi C, Vinciguerra A, Santangelo G, Matera MG, Rossi F.
    Int J Clin Pharmacol Ther; 1994 Feb 09; 32(2):88-91. PubMed ID: 8004364
    [Abstract] [Full Text] [Related]

  • 38. Cefonicid concentration in lung tissue after intramuscular administration.
    Cruciani M, Savio S, Concia E.
    Int J Clin Pharmacol Res; 1987 Feb 09; 7(6):481-4. PubMed ID: 3440639
    [Abstract] [Full Text] [Related]

  • 39. [Excretion of erythromycin, clindamycin and lincomycin into the saliva].
    Kelentey BA, Kelentey BJ.
    Fogorv Sz; 1995 Jul 09; 88(7):219-24. PubMed ID: 8522016
    [Abstract] [Full Text] [Related]

  • 40. [A new antibiotic in the treatment of infections caused by gram positive bacteria: lincomycin. In vitro study and clinical experience].
    Bertrand A, Janbon F.
    Sem Hop; 1967 Dec 08; 43(51):3263-6. PubMed ID: 4299182
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.